Scleroderma

Molecular Differences Between Pediatric & Adult Psoriasis Plaques

July 10, 2017 • By Marilynn Larkin

More Effective Antifibrotic Therapies for Systemic Sclerosis in Development; Adverse Events A Concern

June 14, 2017 • By Susan Bernstein

Stem Cell Transplantation Shown to Improve Outcomes in Systemic Sclerosis

June 14, 2017 • By Mary Beth Nierengarten

Tofacitinib Treatment May Improve Nail Psoriasis

April 24, 2017 • By Rita Buckley

What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities

March 3, 2017 • By Richard Quinn

Certolizumab Pegol Promising for Plaque Psoriasis in Phase 3 Trial

March 1, 2017 • By Michele B. Kaufman, PharmD, BCGP

Distinct Autoantigens Found in Patients with Scleroderma & Coincident Cancer

January 24, 2017 • By Lara C. Pullen, PhD

Targeted Therapy for Scleroderma Fibrosis

October 11, 2016 • By Sara R. Schoenfeld, MD, & Flavia V. Castelino, MD

Rheumatology Case Report: Concomitant Lupus with Features of Scleroderma, Castleman Disease

July 11, 2016 • By Kwabna Parker, MBBS, Sireesha Datla, MD, & Nancy Soloman, MD

Treatments for Scleroderma with Gastrointestinal Involvement Address Symptoms

June 13, 2016 • By Thomas R. Collins